Chemotherapy Induced Nausea and Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape.
Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, drug, dose, schedule of administration and route.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chemotherapy Induced Nausea and Vomiting - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 6, 2, 7, 1, 8, 3 and 2 respectively.
Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
Companies Mentioned
Companies Mentioned
Acacia Pharma Ltd
AcuCort AB
Amzell BV
Aphios Corp
Arovella Therapeutics Ltd
Athenex Inc
Axim Biotechnologies Inc
Benuvia Therapeutics Inc
Bionorica SE
Camurus AB
Daewoong Pharmaceutical Co Ltd
Ethicann Pharmaceuticals Inc
Helsinn Group
Hoverink Biotechnologies Inc
IntelGenx Corp
Jiangsu Hengrui Medicine Co Ltd
LipoSeuticals Inc
LP Pharmaceutical (Xiamen) Co Ltd
Luxena Pharmaceuticals Inc
MannKind Corp
Senzer Ltd
Shackelford Pharma Inc
Skye Bioscience Inc
SoluBest Ltd
Starton Therapeutics Inc
Yichang Humanwell Pharmaceutical Co Ltd
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook